Stock SEDANA SEDANA MEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Sedana Medical AB

Equities

SEDANA

SE0015988373

Market Closed - Nasdaq Stockholm
Other stock markets
 17:00:00 28/06/2024 BST 		5-day change 1st Jan Change
23.15 SEK -1.49% Intraday chart for Sedana Medical AB -4.34% -0.04%
05-29 Sedana Medical AB Completes Patient Recruitment for its Clinical Program in the US CI
05-22 Sedana Medical AB Approves Election of Jens Viebke and Donna Haire as Board Members CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sedana Medical AB Completes Patient Recruitment for its Clinical Program in the US
Sedana Medical AB Approves Election of Jens Viebke and Donna Haire as Board Members
Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US
Ola Magnusson and Eva Walde Decline Re-Election as Board Members of Sedana Medical AB
Sedana Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023
Sedana Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Sedana Medical Seeks Pediatric Indication for Sedaconda Medical Device
Sedana Medical AB Files Submission for Paediatric Indication
Sedana Medical’s Sedaconda Gains Data Exclusivity, Market Protection in Europe
Sedana Medical AB Announces the Main Results from the Paediatric Isocomfort Study
Sedana Medical AB Provides Earnings Guidance for the Year 2023
Sedana Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Sedana Medical AB Establishes Nomination Committee
Sedana Medical Completes Patient Enrollment for Sevoflurane Trial
Sedana Medical AB Announces Completion of Enrollment
Sedana Medical Wins UK Marketing Approval for Isoflurane Drug; Shares Jump 10%
Sedana Medical AB Announces Medicines and Healthcare Products Regulatory Agency Grants Marketing Authorization for Sedaconda in United Kingdom
Sedana Medical Secures US Patent for Anesthetic Administration Medical Device
Sedana Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SEDANA Stock
  4. News Sedana Medical AB
  5. Other languages